FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336247535> ?p ?o ?g. }

• W2336247535 endingPage "189" @default.
• W2336247535 startingPage "179" @default.
• W2336247535 abstract "Aims and background With the recent emergence of immunotherapies and novel targeted treatments for advanced and metastatic melanoma such as selective B-Raf inhibitors and checkpoint inhibitors, the treatment landscape in Europe has changed considerably. The aim of this review was to provide an overview of current treatment pathways in Europe for the treatment of advanced melanoma, unresectable stage III–IV. Methods A literature search of four databases was conducted to identify publications reporting on the treatment patterns of advanced and metastatic melanoma (stage III–IV) in European populations. Results Seven full-text publications and two conference abstracts reported on observational studies of melanoma treatment practices in France, Italy and the United Kingdom. Treatment patterns were identified for two time periods: 2005–2009 and 2011–2012. Common treatments reported for both periods included chemotherapy with dacarbazine, fotemustine or temozolomide. The main differences between the two periods were the introduction and prescription of immunotherapy ipilimumab and targeted therapy vemurafenib between 2011 and 2012. Across the three countries studied, the types of treatments prescribed between 2005 and 2009 were relatively similar, however, with noticeable differences in the frequency and priority of administration. Conclusion Treatment practices for advanced melanoma vary markedly across different European countries and continue to evolve with the introduction of new therapies. The results of this review highlight a considerable evidence gap with regards to recent treatment patterns for advanced melanoma in Europe, especially post-2011 after the introduction of novel therapeutic agents, and more recently with the introduction of programmed cell death 1 inhibitors." @default.
• W2336247535 created "2016-06-24" @default.
• W2336247535 creator A5017787177 @default.
• W2336247535 creator A5025478490 @default.
• W2336247535 creator A5034365278 @default.
• W2336247535 creator A5041846479 @default.
• W2336247535 creator A5060937087 @default.
• W2336247535 creator A5067531937 @default.
• W2336247535 creator A5082171636 @default.
• W2336247535 date "2016-06-01" @default.
• W2336247535 modified "2023-10-17" @default.
• W2336247535 title "Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe" @default.
• W2336247535 cites W1955040029 @default.
• W2336247535 cites W1979748380 @default.
• W2336247535 cites W1987409781 @default.
• W2336247535 cites W1997919830 @default.
• W2336247535 cites W2026707626 @default.
• W2336247535 cites W2030467932 @default.
• W2336247535 cites W2041573530 @default.
• W2336247535 cites W2044732273 @default.
• W2336247535 cites W2052305452 @default.
• W2336247535 cites W2066717393 @default.
• W2336247535 cites W2088542403 @default.
• W2336247535 cites W2110725139 @default.
• W2336247535 cites W2116997650 @default.
• W2336247535 cites W2118863192 @default.
• W2336247535 cites W2130528767 @default.
• W2336247535 cites W2131467528 @default.
• W2336247535 cites W2154683287 @default.
• W2336247535 cites W2158149886 @default.
• W2336247535 cites W2160031991 @default.
• W2336247535 cites W2164895004 @default.
• W2336247535 cites W2168083201 @default.
• W2336247535 cites W4241605155 @default.
• W2336247535 doi "https://doi.org/10.1016/j.ejca.2016.01.011" @default.
• W2336247535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27118416" @default.
• W2336247535 hasPublicationYear "2016" @default.
• W2336247535 type Work @default.
• W2336247535 sameAs 2336247535 @default.
• W2336247535 citedByCount "43" @default.
• W2336247535 countsByYear W23362475352016 @default.
• W2336247535 countsByYear W23362475352017 @default.
• W2336247535 countsByYear W23362475352018 @default.
• W2336247535 countsByYear W23362475352019 @default.
• W2336247535 countsByYear W23362475352020 @default.
• W2336247535 countsByYear W23362475352021 @default.
• W2336247535 countsByYear W23362475352022 @default.
• W2336247535 countsByYear W23362475352023 @default.
• W2336247535 crossrefType "journal-article" @default.
• W2336247535 hasAuthorship W2336247535A5017787177 @default.
• W2336247535 hasAuthorship W2336247535A5025478490 @default.
• W2336247535 hasAuthorship W2336247535A5034365278 @default.
• W2336247535 hasAuthorship W2336247535A5041846479 @default.
• W2336247535 hasAuthorship W2336247535A5060937087 @default.
• W2336247535 hasAuthorship W2336247535A5067531937 @default.
• W2336247535 hasAuthorship W2336247535A5082171636 @default.
• W2336247535 hasConcept C121608353 @default.
• W2336247535 hasConcept C126322002 @default.
• W2336247535 hasConcept C143998085 @default.
• W2336247535 hasConcept C23131810 @default.
• W2336247535 hasConcept C2776131300 @default.
• W2336247535 hasConcept C2777389519 @default.
• W2336247535 hasConcept C2777658100 @default.
• W2336247535 hasConcept C2777701055 @default.
• W2336247535 hasConcept C2780030458 @default.
• W2336247535 hasConcept C2780964509 @default.
• W2336247535 hasConcept C2781230642 @default.
• W2336247535 hasConcept C2781433595 @default.
• W2336247535 hasConcept C2994587330 @default.
• W2336247535 hasConcept C502942594 @default.
• W2336247535 hasConcept C509974204 @default.
• W2336247535 hasConcept C71924100 @default.
• W2336247535 hasConceptScore W2336247535C121608353 @default.
• W2336247535 hasConceptScore W2336247535C126322002 @default.
• W2336247535 hasConceptScore W2336247535C143998085 @default.
• W2336247535 hasConceptScore W2336247535C23131810 @default.
• W2336247535 hasConceptScore W2336247535C2776131300 @default.
• W2336247535 hasConceptScore W2336247535C2777389519 @default.
• W2336247535 hasConceptScore W2336247535C2777658100 @default.
• W2336247535 hasConceptScore W2336247535C2777701055 @default.
• W2336247535 hasConceptScore W2336247535C2780030458 @default.
• W2336247535 hasConceptScore W2336247535C2780964509 @default.
• W2336247535 hasConceptScore W2336247535C2781230642 @default.
• W2336247535 hasConceptScore W2336247535C2781433595 @default.
• W2336247535 hasConceptScore W2336247535C2994587330 @default.
• W2336247535 hasConceptScore W2336247535C502942594 @default.
• W2336247535 hasConceptScore W2336247535C509974204 @default.
• W2336247535 hasConceptScore W2336247535C71924100 @default.
• W2336247535 hasFunder F4320307105 @default.
• W2336247535 hasLocation W23362475351 @default.
• W2336247535 hasLocation W23362475352 @default.
• W2336247535 hasOpenAccess W2336247535 @default.
• W2336247535 hasPrimaryLocation W23362475351 @default.
• W2336247535 hasRelatedWork W2008642727 @default.
• W2336247535 hasRelatedWork W2124587443 @default.
• W2336247535 hasRelatedWork W2401104642 @default.
• W2336247535 hasRelatedWork W2405204261 @default.
• W2336247535 hasRelatedWork W2579054220 @default.

• next